País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Exemestane 25mg
Alchemy Health Limited
25 mg
Film coated tablet
Active: Exemestane 25mg Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Macrogol 400 Macrogol 6000 Magnesium stearate Mannitol Microcrystalline cellulose Polysorbate 80 Purified talc Sodium starch glycolate Titanium dioxide
Prescription
EXEMESTANE is indicated for: · the adjuvant treatment of postmenopausal women with oestrogen receptor positive or receptor unknown early breast cancer after initial adjuvant tamoxifen to reduce the risk of recurrence (distant and loco-regional) and contralateral breast cancer · the treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy · the third-line hormonal treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease progressed following treatment with anti-oestrogens and either non-steroidal aromatase inhibitors or progestins.
Package - Contents - Shelf Life: Blister pack, aluminium PVC/PVDC, contained in cardboard carton - 30 tablets - 36 months from date of manufacture stored at or below 30°C
2020-09-25